In July 2011, Xarelto was approved by the FDA and marketed to consumers as a prescription blood thinner. Xarelto was designed to reduce the risk of blood clots and strokes in patients with atrial fibrillation, treat deep vein thrombosis and pulmonary embolism, and reduce the risk of blood clots in patients undergoing knee or hip replacement surgery.
Unfortunately, there have been
hundreds of negative side effects linked to Xarelto use. The most common side effects include:
- Uncontrolled bleeding
- Death caused by uncontrolled bleeding
- Intestinal bleeding
- Brain hemorrhaging
- Hematomas requiring hospitalization